Thrombin peptide derivatives
View Patent ↗Disclosed are thrombin peptide derivatives comprising a polypeptide having the amino acid sequence SEQ ID NO. 2: Arg-Gly-Asp-Ala-Xaa-Glu-Gly-Asp-Ser-Gly-Gly-Pro-Phe-Val, or a C-terminal truncated fragment of the polypeptide having at least six amino acids. Xaa is alanine, glycine, serine, or an S-protected cysteine. Zero, one, two, or three amino acids in the polypeptide or polypeptide fragment differ from the corresponding position of SEQ ID NO. 2. Also disclosed are methods of treating a subject in need of treatment with a thrombin receptor agonist. The methods comprise the step of administering an effective amount of the thrombin peptide derivative described above.
1. A polypeptide, wherein the amino acid sequence of said polypeptide is Ala-Gly-Tyr-Lys-Pro-Asp-Glu-Gly-Lys-Arg-Gly-Asp-Ala-Xaa-Glu-Gly-Asp-Ser-Gly-Gly-Pro-Phe-Val (SEQ ID NO: 5) or a fragment of said polypeptide, wherein said fragment comprises the amino acid sequence Arg-Gly-Asp-Ala-Xaa-Glu-Gly-Asp-Ser-Gly-Gly-Pro-Phe-Val (SEQ ID NO: 2), wherein said polypeptide or said fragment comprises an N-terminus which is unsubstituted and a C-terminus which is unsubstituted or which comprises an amide represented by —C(O)NH 2 and wherein Xaa is an S-protected cysteine, the thiol of which is blocked with a protecting group, provided that the protecting group is not a second polypeptide comprising SEQ ID NO: 2.
2. A polypeptide, wherein the amino acid sequence of said polypeptide is Ala-Gly-Tyr-Lys-Pro-Asp-Glu-Gly-Lvs-Arg-GIy-Asp-Ala-Xaa-Xi-GIy-Asp-Ser-Gly-Gly-Pro-X 2 -Val (SEQ ID NO: 6) or a fragment of said polypeptide, wherein said fragment of said polypeptide comprises Arg-Gly-Asp-Ala-Xaa-X 1 -Gly-Asp-Ser-Gly-Gly-Pro-X2-Val (SEQ ID NO: 4); wherein Xaa is an S-protected cysteine, the thiol of which is blocked with a protecting group, provided that the protecting group is not a second polypeptide comprising SEQ ID NO:4; and wherein X 1 is Glu or Gln; and X 2 is Phe, Met, Leu, His or Val; and wherein the polypeptide or said fragment comprises an N-terminus which is unsubstituted, and a C-terminus which is unsubstituted or which comprises an amide represented by —C(O)NH 2 .
3. The polypeptide of claim 2 , wherein X 1 is Glu and X 2 is Phe.
4. The polypeptide H-Ala-Gly-Tyr-Lys-Pro-Asp-Glu-Gly-Lys-Arg-Gly-Asp-Ala-Xaa-X 1 -Gly-Asp-Ser-Gly-Gly-Pro-X 2 -Val-R1 (SEQ ID NO: 13), wherein X 1 is Glu or Gln and X 2 is Phe, Met, Leu, His or Val; wherein Xaa is an S-protected cysteine protected as a thioether or thioester; and wherein R1 is —OH or —NH 2 .
5. The polypeptide H-Ala-Gly-Tyr-Lys-Pro-Asp-Glu-Gly-Lys-Arg-Gly-Asp-Ala-Xaa-Glu-Gly-Asp-Ser-Gly-Gly-Pro-Phe-Val-R1 (SEQ ID NO: 15); wherein Xaa is an S-protected cysteine protected as a thioether or thioester; and wherein R1 is —OH or —NH 2 .